Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database.

[1]  A. Renshaw,et al.  Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. , 2002, Urology.

[2]  H. Frierson,et al.  Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years , 2002, Cancer.

[3]  A W Partin,et al.  Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. , 2001, The Journal of urology.

[4]  S. Freedland,et al.  Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. , 2000, Urology.

[5]  J. Epstein,et al.  Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. , 2000, The American journal of surgical pathology.

[6]  M. Resnick,et al.  Analysis of recent trends in prostate cancer incidence and mortality , 2000, The Prostate.

[7]  J. Trachtenberg,et al.  Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up. , 2000, Clinical biochemistry.

[8]  T. Matsuda,et al.  Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan , 2000, Prostate cancer and prostatic diseases.

[9]  H. Levin,et al.  Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Terris.  Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report. , 1999, Urology.

[11]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.

[12]  D. Grignon,et al.  Prostate cancer histologic trends in the metropolitan Detroit area, 1982 to 1996. , 1999, Urology.

[13]  D. Bostwick,et al.  Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. , 1998, Mayo Clinic proceedings.

[14]  C. Chute,et al.  Secular changes in radical prostatectomy utilization rates in Olmsted County, Minnesota 1980 to 1995. , 1998, The Journal of urology.

[15]  J. Stanford,et al.  Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994. , 1997, The Journal of urology.

[16]  P. Carroll,et al.  Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. , 1997, Urology.

[17]  M. Kattan,et al.  Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? , 1997, The Journal of urology.

[18]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[19]  Montie Je.  Controversies in the early detection of prostate cancer. , 1994 .

[20]  W. Catalona,et al.  Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.

[21]  R. Vessella,et al.  The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. , 1993, The Journal of urology.

[22]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[23]  W. Cooner,et al.  Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer. , 1988, Investigative radiology.

[24]  E. Crawford,et al.  Radical retropubic prostatectomy. , 1983, The Journal of urology.

[25]  J. Meehan,et al.  Re: Impotence Following Radical Prostatectomy: Insight into Etiology and Prevention, by Patrick C. Walsh and Pieter J. Donker, J. Urol., 128: 492–497, 1982 , 1983 .

[26]  Gleason Df.  Classification of prostatic carcinomas. , 1966 .

[27]  C. Amling,et al.  Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. , 2000, The Journal of urology.